|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 776.6 USD | +5.35% |
|
+4.60% | +33.81% |
| 08:49pm | Wall Street stocks fall as markets weigh strong wage data, Fed meeting | RE |
| 08:36pm | Trending : Eli Lilly Reports Strong Sales of Weight-Loss, Diabetes Drugs | DJ |
10:10 ET -- Eli Lilly is one of the most mentioned companies in the U.S. across all news items in the past 12 hours, according to Factiva data. The drugmaker said its weight-loss drug, sold in the U.S. as Zepbound, significantly reduced the severity of sleep apnea in obese adults in a pair if late-stage studies. Dow Jones & Co. owns Factiva. (colin.kellaher@wsj.com)
(END) Dow Jones Newswires
04-17-24 1025ET
| 1st Jan change | Capi. | |
|---|---|---|
| +33.88% | 664B | |
| +29.29% | 567B | |
| -7.38% | 354B | |
| +19.07% | 330B | |
| +4.74% | 286B | |
| +13.79% | 234B | |
| +4.93% | 199B | |
| -9.78% | 196B | |
| -4.79% | 148B | |
| -10.98% | 145B |
ELI LILLY AND COMPANY 
